SENSOLIFE Featured at SIM Conference Porto: Shaping the Future of Healthcare

Porto, Portugal — At this year’s SIM Conference (Saúde, Inovação e Medicina), SENSOLIFE was prominently featured as a model of responsible AI innovation — presenting its vision for non-clinical cognitive wellness support in elderly populations, without entering the realm of diagnosis or medical intervention.

Held at Alfândega Congress Centre, SIM 2024 brought together Portugal’s leading healthcare providers, researchers, innovators, and regulators to discuss the evolving interface between medicine, technology, and society.
SENSOLIFE was invited to speak on Day 2’s keynote panel under the theme:
“When AI Listens: The Ethics and Promise of Voice in Health Support.”

A Clear Message: Support, Not Surveillance

Co-founder Davood Mohammad Amini represented SENSOLIFE on stage, joined by experts in geriatric medicine, AI ethics, and public health strategy. His message was simple but powerful:

“We are not here to detect disease. We are here to preserve dignity.”

He emphasized that while SENSOLIFE uses advanced speech analysis to detect changes in rhythm, tone, and verbal fluency, the system never makes assumptions or clinical claims. Instead, it creates a gentle early-alert layer that helps families, caregivers, or medical professionals decide if further assessment is needed.

This message resonated deeply with healthcare practitioners increasingly concerned about AI overreach.

Ethics in Design

The SIM audience praised SENSOLIFE for embedding ethics into its architecture:

• No raw audio is stored
• All data is anonymized and processed locally where possible
• Users can opt out of trend-sharing or family alerts
• No medical labels or classifications are applied

SENSOLIFE was positioned as a best-practice case study in how AI can support human care without replacing clinical judgment or professional responsibility.

Intersections with Medicine — Not Replacements

In breakout workshops, medical professionals tested the SENSOLIFE dashboard and personal AI twin interface.
Geriatricians from Lisbon and Coimbra noted that while the device is not a diagnostic tool, it could serve as:

• A daily cognitive engagement enhancer
• A low-cost alert system for attention decline
• A conversation starter in family–doctor consultations

This feedback validated SENSOLIFE’s stance as a complement, not competitor, to healthcare.

Building Bridges with Academia and Regulators

Following the panel, SENSOLIFE met with:

• Representatives from Portugal’s Health Regulatory Authority (ERS)
• Policy researchers from the University of Minho studying aging ethics
• Coordinators of EU digital health alignment programs

The outcome: preliminary steps toward an ethics-by-design certification framework for voice-based well-being companions.“SENSOLIFE shows that empathy can be engineered — if you begin with the right questions,” said a SIM panel moderator from the National Ethics Commission.

Thought Leadership for the Future

This event marked SENSOLIFE’s transition from pilot project to healthcare thought leader, helping set the tone for how aging tech can be:

• Non-invasive
• Non-diagnostic
• Still deeply impactful

The company’s presence at SIM also drew invitations to upcoming EU health forums focused on “digital public wellness” in 2025.